베인은 홈페이지 기능 및 성능 개선을 위해 쿠키를 사용합니다. 이와 관련된 더 많은 정보는 개인정보 메뉴에서 확인하실 수 있습니다. 이 웹사이트를 계속 사용하시면 쿠키 사용에 동의하신 것으로 간주됩니다. 

사례 연구

Divestiture adds value to parent, subsidiary

An international manufacturer and distributor of medical equipment, devices and pharmaceuticals was struggling to resume profitable growth. Bain assessed a range of possible growth models and recommended spinning off the company from its large industrial parent. The spin-off increased the parent company's market capitalization by $500 million.

  • 읽기 소요시간

한눈에 보기

  • $500M increased market capitalization of parent company

전체보기

The Situation

TotalMedCo* was a $1 billion international manufacturer and distributer of medical equipment, devices and pharmaceuticals. It was a subsidiary of IndustryGiant, a large industrial company whose primary business was in other areas.

When its leading drug came off patent, TotalMedCo was forced to scale back capital investment and reduce spending on R&D and marketing just to stabilize its business.

IndustryGiant* asked Bain to advise on a strategy to generate profitable growth and maximize the value of TotalMedCo.

Our Approach

Bain embarked upon a complete evaluation of capabilities and opportunities which weighed organic growth against acquisition/partnership models.

 

Our Recommendations

The strategy with the most promise for TotalMedCo would have required massive investments from IndustryGiant. In light of this, divesting the subsidiary was the best solution.

 

The Results

IndustryGiant opted to divest TotalMedCo rather than make new investments. Bain's work helped demonstrate the full potential of each of TotalMedCo's businesses, increasing the value created from the spin-offs and divestitures.

 

* We take our clients' confidentiality seriously. While we've changed their names, the results are real. 

베인에 궁금하신 점이 있으신가요?

베인은 글로벌 리더들이 중요한 이슈를 해결하고 기회를 놓치지 않도록 지원합니다. 고객사와 협력하여 지속되는 변화와 성과를 창출합니다.